Retrospective Study
Copyright ©The Author(s) 2016.
World J Hepatol. Feb 8, 2016; 8(4): 226-230
Published online Feb 8, 2016. doi: 10.4254/wjh.v8.i4.226
Table 1 Transplant details and patient survival
Sex, ageIndicationMELDToxic liver syndromeCVVHHptc before graft availabilityInotrope requirementsAnhepatic phase (h)Survival (mo)
1F, 26Paracetamol overdose39YesNoYesYes7116
2M, 41Heat stroke40YesYesYesYes1622
3M, 47Fulminant hepatits A40YesYesNoYes5.512 h
4M, 20Paracetamol overdose40YesNoNoNo5.8107
5F, 30Paracetamol overdose36YesYesYesYes44108
6M, 21Liver trauma28NoNoYesNo15106
Table 2 Biochemical data pre and post transplant
No. of patientDose NApHBicarbonate (mmol/L)Lactate (mmol/L)INRSodium (mmol/L)Potasium (mmol/L)
Before Hptc707.1411.305.3211.251333.9
1Anhepatic807.2417.207.32.501333.7
Post reperfusion607.2716.4061.851355.4
Before Hptc647.1513.309.2015.801365.5
2Anhepatic807.2614.00113.331374.5
Post reperfusion207.2014.60102.271453.9
Before Hptc507.0614.7010.20131384.8
3Anhepatic367.1713.30101.751434.9
Post reperfusion487.1213.8010.51.751465.0
Before HptcNone7.3411.105.30171333.6
4Anhepatic107.3420.704.202.901333.6
Post reperfusion57.3218.603.71.641363.8
Before Hptc2007.1611.3012.006.31483.7
5Anhepatic687.2618.0012.303.011414.2
Post reperfusion327.1914.006.72.471445.20
Before HptcNone7.0210.703.3010.591515.0
6Anhepatic1206.9113.507.72.461464.3
Post reperfusion107.0112.707.71.611443.8
Before Hptc677.1411.37.2612.121374.35
(50-200)(7.02-7.34)(10.70-14.7)(3.3-12)(6.3-17)(133-152)(3.6-5.5)
MedianAnhepatic747.2515.68.852.71394.3
range(10-120)(6.91-7.34)(13.30-20.70)(4.2-12.3)(1.75-3.33)(133-146)(3.6-4.9)
Post reperfusion267.1914.314.31.81444.45
(5-60)(7.01-7.32)(12.7-18.60)(12.7-18.60)(1.61-2.47)(135-146)(3.8-5.4)